| Natural history and decolonization strategies for ESBL/carbapenem-resistant Enterobacteriaceae carriage: systematic review and meta-analysis H Bar-Yoseph, K Hussein, E Braun, M Paul Journal of Antimicrobial Chemotherapy 71 (10), 2729-2739, 2016 | 183 | 2016 |
| Cell-centred meta-analysis reveals baseline predictors of anti-TNFα non-response in biopsy and blood of patients with IBD R Gaujoux, E Starosvetsky, N Maimon, F Vallania, H Bar-Yoseph, ... Gut 68 (4), 604-614, 2019 | 174 | 2019 |
| Association of induction infliximab levels with clinical response in perianal Crohn’s disease Y Davidov, B Ungar, H Bar-Yoseph, D Carter, O Haj-Natour, M Yavzori, ... Journal of Crohn's and Colitis 11 (5), 549-555, 2017 | 143 | 2017 |
| Early drug and anti‐infliximab antibody levels for prediction of primary nonresponse to infliximab therapy H Bar‐Yoseph, N Levhar, L Selinger, U Manor, M Yavzori, O Picard, ... Alimentary pharmacology & therapeutics 47 (2), 212-218, 2018 | 76 | 2018 |
| Regulation of S100A8 stability by RNF5 in intestinal epithelial cells determines intestinal inflammation and severity of colitis YU Fujita, A Khateb, Y Li, R Tinoco, T Zhang, H Bar-Yoseph, MA Tam, ... Cell reports 24 (12), 3296-3311. e6, 2018 | 54 | 2018 |
| Oral Capsulized Fecal Microbiota Transplantation for Eradication of Carbapenemase-producing Enterobacteriaceae Colonization With a Metagenomic Perspective H Bar-Yoseph, S Carasso, S Shklar, A Korytny, R Even Dar, H Daoud, ... Clinical infectious diseases 73 (1), e166-e175, 2021 | 50 | 2021 |
| The effect of indirect calorimetry guided isocaloric nutrition on mortality in critically ill patients—A systematic review and meta-analysis B Pertzov, H Bar-Yoseph, Y Menndel, I Bendavid, I Kagan, YD Glass, ... European Journal of Clinical Nutrition 76 (1), 5-15, 2022 | 29 | 2022 |
| Infliximab–tumor necrosis factor complexes elicit formation of anti-drug antibodies H Bar-Yoseph, S Pressman, A Blatt, SG Vainberg, N Maimon, ... Gastroenterology 157 (5), 1338-1351. e8, 2019 | 25 | 2019 |
| Prevention of antidrug antibody formation to infliximab in Crohn's patients with prior failure of thiopurines H Bar-Yoseph, M Waterman, R Almog, T Billiet, S Vermeire, B Ungar, ... Clinical Gastroenterology and Hepatology 15 (1), 69-75, 2017 | 25 | 2017 |
| Morphological embryo assessment: reevaluation H Bar-Yoseph, A Levy, Y Sonin, S Alboteanu, E Levitas, E Lunenfeld, ... Fertility and sterility 95 (5), 1624-1628. e2, 2011 | 24 | 2011 |
| Severe cytomegalovirus enterocolitis developing following daratumumab exposure in three patients with multiple myeloma N Lavi, D Okasha, E Sabo, I Oren, N Benyamini, H Bar‐Yoseph European journal of haematology 101 (5), 699-702, 2018 | 21 | 2018 |
| Risk factors for mortality among carbapenem-resistant enterobacteriaceae carriers with focus on immunosuppression H Bar-Yoseph, N Cohen, A Korytny, ER Andrawus, RE Dar, Y Geffen, ... Journal of Infection 78 (2), 101-105, 2019 | 17 | 2019 |
| Strongyloidiasis-related IRIS: a case report and literature review H Bar-Yoseph, Y Zohar, M Lorber Journal of the International Association of Providers of AIDS Care (JIAPAC …, 2017 | 10 | 2017 |
| Effects of Gut Microbiota Alterations on Motor, Gastrointestinal, and Behavioral Phenotype in a Mouse Model of Parkinson’s Disease N Radisavljevic, M Cirstea, K Bauer, C Lo, A Metcalfe-Roach, ... Journal of Parkinson's Disease 12 (5), 1479-1495, 2022 | 6 | 2022 |
| Association of induction infliximab levels with clinical response in perianal Crohn’s disease. J Crohns Colitis. 2017; 11 (5): 549–55 Y Davidov, B Ungar, H Bar-Yoseph, D Carter, O Haj-Natour, M Yavzori Epub 2017/04/30. doi: 10.1093/ecco-jcc/jjw182. PubMed PMID: 28453755, 0 | 5 | |
| Omitting ciprofloxacin prophylaxis in patients undergoing allogeneic hematopoietic stem cell transplantation and its impact on clinical outcomes and microbiome structure H Daoud-Asfour, I Henig, I Ghersin, S Rakedzon, A Stern, M Pitashny, ... Transplantation and Cellular Therapy 28 (3), 168. e1-168. e8, 2022 | 4 | 2022 |
| Does early corticosteroid therapy affect prognosis in IBD patients hospitalized with Clostridioides difficile infection? H Bar-Yoseph, H Daoud, D Ben Hur, Y Chowers, M Waterman International Journal of Colorectal Disease 35, 513-519, 2020 | 4 | 2020 |
| Tu1167 Infliximab Is More Immunogenic and Reaches Lower Trough Levels in Ulcerative Colitis Patients Compared to Crohn's Disease Patients H Bar-yoseph, Y Chowers, S Ben-Horin, M Waterman Gastroenterology 5 (144), S-780, 2013 | 4 | 2013 |
| A personalized network framework reveals predictive axis of anti-TNF response across diseases S Gerassy-Vainberg, E Starosvetsky, R Gaujoux, A Blatt, N Maimon, ... Cell Reports Medicine 5 (1), 2024 | 3 | 2024 |
| Efficacy of a hospital policy of selective digestive decontamination for carbapenem-resistant enterobacterales carriers: Prospective before–after study H Bar-Yoseph, C Lulu, S Shklar, A Korytny, RE Dar, H Daoud, K Hussein, ... Journal of Hospital Infection 106 (3), 495-499, 2020 | 3 | 2020 |
